Bigul

WHO approval for AstraZeneca vaccine should come soon: Serum CEO

Serum CEO Poonawalla said his company would start stockpiling millions of doses of the Novavax coronavirus vaccine candidate from around April
14-01-2021
Bigul

WHO awaits Serum Institute data to recommend Covid-19 vaccine for international use

The World Health Organization is awaiting data from Serum Institute of India (SII) on the AstraZeneca-OxfordUniversity Covid-19 vaccine, so it can be
13-01-2021

COVID-19 Vaccine Update: Recipients cannot choose between Covishield and Covaxin initially, says report

The Drugs Controller General of India (DCGI) had recently granted emergency use authorisation to two COVID-19 vaccines Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin.
13-01-2021
Bigul

Serum Institute gets 'Covishield' purchase order from Centre

The Serum Institute on India on Monday said it has received the purchase order from the Centre for the Oxford-AstraZeneca Covid-19 vaccine."We have
11-01-2021
Bigul

Serum Institute may supply around 400 million more doses to Gavi-Covax

Serum Institute already has two deals of 100 million each to supply the Oxford-AstraZeneca and the Novavax vaccine to Gavi-Covax at $3 per dose
09-01-2021
Bigul

Covid-19 vaccines across the globe get the go ahead

Vaccines are on the move across the globe, as AstraZeneca, Moderna and Gamaleya Institute get the green-light for their Covid-19 vaccines in differen
07-01-2021

Health Minister Harsh Vardhan reviews preparedness for second COVID-19 vaccination dry run

India's drug regulator has granted restricted emergency use approval to Oxford-AstraZeneca's Covishield and the indigenously developed Covaxin of Bharat Biotech.
07-01-2021
Bigul

All Indian vaccines have to be stored at 2-8 degree Celsius: DBT secy

Department of Biotechnology Secretary Renu Swarup said Bharat Biotech's COVID-19 vaccine Covaxin and Oxford-AstraZeneca's Covishield have robustly undergone immunoassay lab tests
05-01-2021
Bigul

Mexico approves AstraZeneca's coronavirus vaccine for emergency use

Mexico approved the Oxford-AstraZeneca coronavirus vaccine for emergency use Monday, hoping to spur a halting vaccination effort that has only given about 44,000 shots since the third week of December
05-01-2021
Next Page
Close

Let's Open Free Demat Account